681. Transcranial magnetic stimulation reveals altered GABAergic and glutamatergic activity in treatment-resistant schizophrenia
Abstract Background Treatment-resistant schizophrenia (TRS), affecting roughly one-third of patients, shows poor response to standard antipsychotics and may reflect more severe or distinct neurophysiological disruptions compared to treatment-responsive cases. Prior evidence from imaging and other methods suggested cort...